Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Why Making Dramatic Moves: OncoGenex Pharmaceuticals (NASDAQ:OGXI), ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Progenics Pharmaceuticals (NASDAQ:PGNX), Keurig Green Mountain (NASDAQ:GMCR), Eastman Chemical (NYSE:EMN) - Property Mentor Group

Property Mentor Group

Why Making Dramatic Moves: OncoGenex Pharmaceuticals (NASDAQ:OGXI), ImmunoCellular Therapeutics, (NYSEMKT:IMUC), Progenics Pharmaceuticals (NASDAQ:PGNX), Keurig Green Mountain (NASDAQ:GMCR), Eastman Chemical (NYSE:EMN)

On Friday shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) closed at $1.90. Company’s sales growth for last 5 years was 1.20%. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced that it will report its first quarter 2015 financial results on Thursday, May 14, 2015.

ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) in last trading activity advanced 1.09% to close at $0.46. Company weekly performance is 0.43% while its quarterly performance stands at -31.61%. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) is -67.94% away from its 52 week high. ImmunoCellular Therapeutics, Ltd. (NYSEMKT:IMUC) announced that Andrew Gengos, President and Chief Executive Officer, presented live at VirtualInvestorConferences.com on May 7, 2015.

On last trading day Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) advanced 6.27% to close at $5.59. Its volatility for the week is 10.57% while volatility for the month is 6.88%. PGNX’s sales growth for past 5 years was -1.90% and its EPS growth for past 5 years was 15.60%. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) monthly performance is -4.93%. TheStreet upgraded shares of Progenics Pharmaceuticals (NASDAQ:PGNX) from a sell rating to a hold rating in a report issued on Wednesday.

Keurig Green Mountain, Inc. (NASDAQ:GMCR) has 0.30% insider ownership while its institutional ownership stands at 64.80%. In last trading activity company’s stock closed at $101.49. On May 06, Keurig Green Mountain, Inc. (NASDAQ:GMCR), announced that Peter G. Leemputte will join the company in June 2015 and will assume the role of Chief Financial Officer and Treasurer effective August 17, 2015.

On last trading day Eastman Chemical Co. (NYSE:EMN) advanced 2.26% to close at $80.08. Its volatility for the week is 1.53% while volatility for the month is 1.90%. EMN’s sales growth for past 5 years was 16.70% and its EPS growth for past 5 years was 36.40%. Eastman Chemical Co. (NYSE:EMN) monthly performance is 11.38%. On May 7, the board of directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.40 per share on the company`s common stock.

Jason Burroughs

,
, , , , , , , , , , , , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *